Earnings Feed
Start Free
Home/Filings/4/0001144204-10-029301
4//SEC Filing

DiCorleto Paul E 4

Accession 0001144204-10-029301

CIK 0001318641other
View on SEC.govCompany Profile

Filed

May 19, 8:00 PM ET

Accepted

May 20, 4:33 PM ET

Size

8.3 KB

Accession

0001144204-10-029301

Insider Transaction Report

Form 4
Period: 2010-05-18
CLEVELAND BIOLABS INCCBLI
DiCorleto Paul E
Director
Transactions
  • Award

    Common Stock

    2010-05-18+7,267→ 7,267 total
Holdings

  • Stock Options (Right to Buy)

    Exercise: $9.40From: 2007-06-12Exp: 2017-06-11→ Common Stock (35,000 underlying)
    35,000

  • Stock Options (Right to Buy)

    Exercise: $5.88From: 2008-04-29Exp: 2018-04-28→ Common Stock (35,000 underlying)
    35,000

  • Stock Options (Right to Buy)

    Exercise: $3.33From: 2009-06-25Exp: 2019-06-24→ Common Stock (35,000 underlying)
    35,000

Documents

1 file

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

→
Entity typeother

Related Parties

1
  • filerCIK 0001370082

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:33 PM ET
Size
8.3 KB
View on SEC.gov